Subtype
Plexiform Neurofibroma
CI-CAN-00003709Explore in graph →
Non-malignant16 active trials2 evidence items
Loading cancer entity…
Subtype
CI-CAN-00003709Explore in graph →
Clinical trials
34 studies whose conditions map to this entity or one of its descendants. Status and phase are as posted on ClinicalTrials.gov. 50 studies per page.
| NCT | Title | Status | Phase | Enrollment (n) | Sponsor | Countries | Last update | Source |
|---|---|---|---|---|---|---|---|---|
| NCT07024394 | Follow-up Study to Evaluate the Safety and Efficacy of FCN-159 in Pediatric Participants With Neurofibromatosis Type 1 | not yet recruiting | Phase 1 / Phase 2 | 65 | Shanghai Fosun Pharmaceutical Industrial Development Co. Ltd.INDUSTRY | 1 | Jun 17, 2025 | clinicaltrials |
Data updated 22 days agoSource updated Jun 17, 2025source: clinicaltrials